Two-drug combo was approved  by FDA to treat metastatic melanoma following the results of clinical trials suggesting the combination is highly effective. The two-drug combo was awarded priority review status due to the outstanding results observed in the clinical trials. The FDA has now approved the combination as it both slows tumor growth and prevents […]